elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39455947-E19A626E-1971-4E57-AE21-B50347010A59
Q39455947-E19A626E-1971-4E57-AE21-B50347010A59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39455947-E19A626E-1971-4E57-AE21-B50347010A59
Multivalent rituximab lipid nanoparticles as improved lymphoma therapies: indirect mechanisms of action and in vivo activity.
P2860
Q39455947-E19A626E-1971-4E57-AE21-B50347010A59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39455947-E19A626E-1971-4E57-AE21-B50347010A59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
826c710ccb65b958efa624ee42fa844555a38895
P2860
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.